Sildenafil Tablets, USP : 25 mg, 50 mg and 100 mg

Ajanta Pharma USA Inc

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating
Safety risk rating
Environmental risk rating

General Information

Product name

Sildenafil Tablets, USP : 25 mg, 50 mg and 100 mg

Chemical name

Therapeutic Category

CAS No.

171599-83-0

1.2.1 Relevant identified uses

Treatment of Erectile dysfunction

Icons in SDS

Company Information

company name

Ajanta Pharma USA Inc

Section 2

Health hazards

information

Potential health effects

Inhalation Not expected to be hazardous in final pharmaceutical form. Eye Contact Not expected to be hazardous in final pharmaceutical form. Skin Contact Not expected to be hazardous in final pharmaceutical form. Ingestion Health injuries are not known or expected under normal use. Exposures above clinical dosage could result in adverse effects. Minor occupational exposures are not expected to be harmful Effects of Overexposure : The potential for exposure is reduced in finished pharmaceutical dosage form.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.